Aortic Root Disease in Athletes: Aortic Root Dilation, Anomalous Coronary Artery, Bicuspid Aortic Valve, and Marfan’s Syndrome
Many forms of aortic root disease afflict athletes and need to be appreciated by sports medicine practitioners because of their potential to lead to tragic but preventable deaths in an otherwise healthy population.
Can an Athlete Have Too Much Ticker? Hypertrophic Cardiomyopathy in Young Athletes
Sudden cardiac death (SCD) is an uncommon but devastating potential consequence of participation in competitive sport.
Renal Function Changes and Seasonal Temperature in Patients Undergoing Cardiac Surgery
The objective of this study is to determine if temperature-dependent seasonal changes in levels of serum creatinine (SC) and estimated glomerular filtration rate (eGFR) are detectable in cardiac surgery patients, with associated changes in postoperative acute kidney injury (AKI) incidence.
High-Intensity Track and Field training in a Cardiac Rehabilitation Program
A 65-year-old male athlete with coronary artery disease enrolled in our cardiac rehabilitation (CR) program after successful coronary artery bypass graft surgery following an acute myocardial infarction.
Arterial Grafts Do Not Counteract Target Vessel Occlusion
Grafted, non-occluded coronary arteries might contribute substantially to the myocardial blood supply and serve as a basis for vascular collateralization which preserves the myocardium in the event of graft occlusion.
Augmentation of Thrombin Generation in Neonates Undergoing Cardiopulmonary Bypass
We compared recombinant activated factor VII (rFVIIa) with three-factor prothrombin complex concentrate (3F-PCC) for the ability to augment thrombin generation (TG) in neonatal plasma after cardiopulmonary bypass (CPB).
Fibrinogen Recovery and Changes in Fibrin-Based Clot Firmness after Cryoprecipitate Administration in Patients Undergoing Aortic Surgery Involving Deep Hypothermic Circulatory Arrest
Cryoprecipitate may be used to treat bleeding in cardiac surgery. Its effects on plasma fibrinogen and fibrin clotting in this setting are poorly defined.
Results of the Minimally Invasive Coronary Artery Bypass Grafting Angiographic Patency Study
The Minimally Invasive Coronary Artery Bypass Grafting Patency Study prospectively evaluated angiographic graft patency 6 months after minimally invasive coronary artery bypass grafting.
Identification of Modifiable Risk Factors for Acute Kidney Injury after Coronary Artery Bypass Graft Surgery in an Asian Population
We aimed to ascertain whether the lowest hematocrit during CPB, preoperative anemia, and intraoperative transfusion remained as independent modifiable risk factors associated with AKI in our prospective cohort of Asians.
Results of the Minimally Invasive Coronary Artery Bypass Grafting Angiographic Patency Study
The Minimally Invasive Coronary Artery Bypass Grafting Patency Study prospectively evaluated angiographic graft patency 6 months after minimally invasive coronary artery bypass grafting.
Comparison Between Five-Year Mortality of Patients With and Without Red Blood Cell Transfusion after Percutaneous Coronary Intervention for ST-Elevation Acute Myocardial Infarction
This study evaluates the long-term impact on the prognosis of patients who received a RBC transfusion after PCI for the treatment of ST-segment elevation MI (STEMI).
Morbidity But Not Mortality Is Decreased After Off-Pump Coronary Artery Bypass Surgery
This retrospective study compared outcomes between on-pump and off-pump CABG from a large multicenter cohort of propensity-matched patients.